In Vivo Antibacterial Activity of MRX-I, a New OxazolidinoneLI, Cong-Ran; ZHAI, Qian-Qian; CHEN, Le-Tian et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 4, pp 2418-2421, issn 0066-4804, 4 p.Article

New oxazolidinone antibacterial agentsGOMEZ-VIDAL, José A; GALLO-MEZO, Miguel A; ESPINOSA, Antonio et al.2005, pp 49-82, isbn 81-7736-291-7, 1Vol, 34 p.Article

In Vivo Activity of the Pyrrolopyrazolyl-Substituted Oxazolidinone RWJ-416457HILLIARD, Jamese J; FERNANDEZ, Jeffrey; MELTON, John et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 5, pp 2028-2033, issn 0066-4804, 6 p.Article

New oxazolidinonesVARA PRASAD, J. V. N.Current opinion in microbiology. 2007, Vol 10, Num 5, pp 454-460, issn 1369-5274, 7 p.Article

Oxazolidinone : Search for highly potent antibacterialBRAJ BHUSHAN LOHRAY; VIDYA BHUSHAN LOHRAY; BRIJESH KUMAR SRIVASTAVA et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 12, pp 3139-3142, issn 0960-894X, 4 p.Article

Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolatesJONES, Ronald N; MOET, Gary J; SADER, Helio S et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 5, pp 804-807, issn 0305-7453, 4 p.Article

In Vitro and In Vivo Activities of LCB01-0371, a New OxazolidinoneJEONG, Ji-Woong; JUNG, Sung-Ji; KWAK, Jin-Hwan et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 12, pp 5359-5362, issn 0066-4804, 4 p.Article

Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolidHOWE, Robin A; WOOTTON, Mandy; NOEL, Alan R et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 11, pp 3651-3652, issn 0066-4804, 2 p.Article

Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk ReductionGUTSTEIN, D. E; KRISHNA, R; JOHNS, D et al.Clinical pharmacology and therapeutics. 2012, Vol 91, Num 1, pp 109-122, issn 0009-9236, 14 p.Article

Anacetrapib: Hope for CETP Inhibitors?GURFINKEL, Ronen; JOY, Tisha R.Cardiovascular therapeutics (Print). 2011, Vol 29, Num 5, pp 327-339, issn 1755-5914, 13 p.Article

Practical synthesis of fluorous oxazolidinone chiral auxiliaries from α-amino acidsHEIN, Jason E; GEARY, Laina M; JAWORSKI, Ashley A et al.Journal of organic chemistry. 2005, Vol 70, Num 24, pp 9940-9946, issn 0022-3263, 7 p.Article

Relaxation spectrum of polyisocyanurate with terminal oxazolidone groupsKRAMARENKO, V. Yu; PRIVALKO, V. P.Polymer science. Series A. 2004, Vol 46, Num 2, pp 143-150, 8 p.Article

Absolute bioavailability and pharmacokinetics of linezolid in hospitalized patients given enteral feedingsBERINGER, Paul; NGUYEN, Megan; HOEM, Nils et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 9, pp 3676-3681, issn 0066-4804, 6 p.Article

Linezolid treatment of ventriculoperitoneal shunt infection without implant removalCASTRO, P; SORIANO, A; ESCRICH, C et al.European journal of clinical microbiology & infectious diseases (Print). 2005, Vol 24, Num 9, pp 603-606, issn 0934-9723, 4 p.Article

Linezolid use associated with lactic acidosisKOPTERIDES, Petros; PAPADOMICHELAKIS, Evangelos; ARMAGANIDIS, Apostolos et al.Scandinavian journal of infectious diseases. 2005, Vol 37, Num 2, pp 153-154, issn 0036-5548, 2 p.Article

Oxazolidinones: activity, mode of action, and mechanism of resistanceBOZDOGAN, Bülent; APPELBAUM, Peter C.International journal of antimicrobial agents. 2004, Vol 23, Num 2, pp 113-119, issn 0924-8579, 7 p.Article

Linezolid: a review of safety and tolerabilityVINH, Donald C; RUBINSTEIN, Ethan.The Journal of infection. 2009, Vol 59, issn 0163-4453, S59-S74, SUP1Article

Le linézolide, premier antibiotique de la famille des oxazolidinones = Linezolid, the first oxazolidinone antibioticDUTRONC, H; BOCQUENTIN, F; GALPERINE, T et al.Médecine et maladies infectieuses. 2005, Vol 35, Num 9, pp 427-434, issn 0399-077X, 8 p.Article

Safety and tolerability of linezolidFRENCH, Gary.Journal of antimicrobial chemotherapy (Print). 2003, Vol 51, pp ii45-ii53, issn 0305-7453, SUP2Article

In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial AgentSCHAADT, Ronda; SWEENEY, Debora; SHINABARGER, Dean et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 8, pp 3236-3239, issn 0066-4804, 4 p.Article

In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteriaVERA-CABRERA, Lucio; BROWN-ELLIOTT, Barbara A; WALLACE, Richard J et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 12, pp 4027-4029, issn 0066-4804, 3 p.Article

Linezolid therapy for orthopedic InfectionsRAZONABLE, Raymund R; OSMON, Douglas R; STECKELBERG, James M et al.Mayo Clinic proceedings. 2004, Vol 79, Num 9, pp 1137-1144, issn 0025-6196, 8 p.Article

In vitro and in vivo activities of DA-7867, a new oxazolidinone, against aerobic gram-positive bacteriaEUN JEONG YOON; YEONG WOO JO; SUNG HAK CHOI et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 6, pp 2498-2500, issn 0066-4804, 3 p.Article

Limited detectability of linezolid-resistant Staphylococcus aureus by the Etest method and its improvement using enriched mediaIKEDA-DANTSUJI, Yurika; NAKAE, Taiji; KOHNO, Shigeru et al.Journal of medical microbiology. 2012, Vol 61, Num 7, pp 998-1002, issn 0022-2615, 5 p.Article

Synthesis of Cyanoacetyl OxazolidinonesWEEBER, Kaitlyn M; SCHWARZ, Jacob B.Synthesis (Stuttgart). 2012, Num 13, pp 1993-1996, issn 0039-7881, 4 p.Article